Teeing Up Futures: Spectrum Investment Advisors Cristo Rey Scholarship Golf Outing
This year's scholarship recipients are
Winners are selected by a dedicated committee that evaluates applicants based on the following criteria:
- Good financial standing with Cristo Rey Jesuit High School
- Strong academic performance
- A clear interest in pursuing a degree in Business or Finance
Diego and Kenia exemplify the values and potential this scholarship was designed to support, and we're proud to help launch their college journeys.
The outing was originally created in memory of a dear friend of the firm who passed away unexpectedly. His passion for
One of the most moving moments is the awards dinner, where scholarship recipients share their goals and personal stories. Hearing their testimonies reminds us why this event matters—it's about more than golf; it's about opening doors.
Each year, the outing grows in spirit and support. This year,
And to top it off, we added a lively new twist—a local conga band that brought rhythm, joy, and a festive energy to the day.
At Spectrum, we believe that when you invest in people, you build a stronger future.
About Spectrum Investment Advisors
Spectrum Investment Advisors was incorporated in 1995. Spectrum is a Registered Investment Adviser built on the premise that achieving one's financial goals depends on independent financial advice, timely research, and easy access to the investments and services that best fit an investor's specific needs. Registration with the SEC does not imply a certain level of skill or training.
View original content to download multimedia:https://www.prnewswire.com/news-releases/teeing-up-futures-spectrum-investment-advisors-cristo-rey-scholarship-golf-outing-302560924.html
SOURCE Spectrum Investment Advisors
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TWO to repurchase $115M in senior notes after CrossCountry merger
- Fermi founder files proposal seeking independent strategic review
- Sacituzumab Govitecan Plus Pembrolizumab Does Not Meet Primary Endpoints in First-Line PD-L1-High Metastatic NSCLC
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share